Maytham Hussein
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Microbiology top 5%
- Antimicrobial Peptides and Activities
- Bacterial Infections and Vaccines
Papers in
-
- Antibiotic Resistance in Bacteria 20
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 9
- Microbial Natural Products and Biosynthesis 4
- Co-authors
- Tony Velkov (31 shared papers)Jian Li (27 shared papers)Elena K. Schneider‐Futschik (9 shared papers)John A. Karas (4 shared papers)Yan Zhu (8 shared papers)Haijin Xu (1 shared paper)Gergely L. Lukács (1 shared paper)Mark A. Hancock (1 shared paper)
- Journals
- Journal of Visualized Experiments (4 papers)Computational and Structural Biotechnology Journal (4 papers)ACS Infectious Diseases (3 papers)mSystems (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Maytham Hussein
29 papers receiving 708 citations
Peers
Comparison fields: 5 of 91
- Molecular Medicine 185
- Microbiology 91
- Applied Microbiology and Biotechnology 22
- Pharmacology 152
- Pulmonary and Respiratory Medicine 178
Countries citing papers authored by Maytham Hussein
This map shows the geographic impact of Maytham Hussein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maytham Hussein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maytham Hussein more than expected).
Fields of papers citing papers by Maytham Hussein
This network shows the impact of papers produced by Maytham Hussein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maytham Hussein. The network helps show where Maytham Hussein may publish in the future.
Co-authors
The 25 scholars most cited alongside Maytham Hussein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 185 | |
| 2 | 2020 | 86 | |
| 3 | 2016 | 50 | |
| 4 | 2020 | 48 | |
| 5 | 2019 | 38 | |
| 6 | 2018 | 33 | |
| 7 | 2019 | 31 | |
| 8 | 2020 | 27 | |
| 9 | 2020 | 25 | |
| 10 | 2022 | 24 | |
| 11 | 2022 | 22 | |
| 12 | 2018 | 20 | |
| 13 | 2023 | 17 | |
| 14 | 2023 | 16 | |
| 15 | 2017 | 16 | |
| 16 | 2018 | 14 | |
| 17 | 2019 | 13 | |
| 18 | 2022 | 12 | |
| 19 | 2003 | 7 | |
| 20 | 2022 | 7 |
About Maytham Hussein
Maytham Hussein is a scholar working on Molecular Medicine, Pharmacology, Epidemiology, Microbiology and Infectious Diseases, having authored 32 papers that have together received 716 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (20 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Antimicrobial Peptides and Activities (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Epilepsy research and treatment (4 papers), Microbial Natural Products and Biosynthesis (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Wound Healing and Treatments (2 papers). The work is most often cited by research in Molecular Medicine (185 citations), Microbiology (91 citations), Applied Microbiology and Biotechnology (22 citations), Pharmacology (152 citations) and Pulmonary and Respiratory Medicine (178 citations). Maytham Hussein has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Tony Velkov, Jian Li, Elena K. Schneider‐Futschik, John A. Karas, Yan Zhu, Haijin Xu, Gergely L. Lukács, Mark A. Hancock, Ariel Roldán and Mark A. Baker. Their work appears in journals such as Journal of Visualized Experiments, Computational and Structural Biotechnology Journal, ACS Infectious Diseases, mSystems and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.